Status | Study |
Terminated |
Study Name: Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia Condition: Polycythemia Vera Essential Thrombocythemia Date: 2013-11-25 Interventions: Drug: Momelotinib Momelotinib tablet administered orally once daily |
Completed |
Study Name: Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera Condition: Polycythemia Vera Date: 2013-09-06 Interventions: Drug: Peg-P-IFN-alpha-2b (AOP2014) |
Recruiting |
Study Name: A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera Condition: Polycythemia Vera Date: 2013-07-10 Interventions: Drug: Givinostat In Part A patients will treated in dose l |
Terminated |
Study Name: Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) Condition: Polycythemia Vera Date: 2012-07-17 Interventions: Drug: Hydroxyurea Procedure: Phlebotomy |
Completed |
Study Name: Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study Condition: Polycythemia Vera Date: 2012-06-29 Interventions: Drug: Ruxolitinib Ruxolitinib |
Active, not recruiting |
Study Name: Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) Condition: Polycythemia Vera Date: 2010-11-17 Interventions: Drug: ruxolitinib tablets Star |
Completed |
Study Name: Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera Condition: Essential Thrombocythemia Polycythemia Vera Date: 2010-11-11 Interventions: Drug: Imetelstat |
Active, not recruiting |
Study Name: Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera Condition: Polycythemia Vera Date: 2010-09-01 Interventions: Drug: PEG-P-INF alpha-2b (P1101) µg (starting with 50 µg), subcutaneously, 2-weekly administra |
Completed |
Study Name: Treatment of Polycythemia Vera With Gleevec Condition: Polycythemia Vera Date: 2010-05-07 Interventions: Drug: Gleevec 400 mg once daily for 12 months Other |
Terminated |
Study Name: Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera Condition: Polycythemia Vera Date: 2009-12-22 Interventions: Drug: Erlotinib Erlotinib supplied as tablets; oral dose of erlotinib of 150 mg daily to be continued fo |